Certain NSCLC Subgroups May Not Benefit From Immunotherapy :

A comprehensive study exploring NSCLC subgroup responses to immunotherapy may help determine which patients are less likely to benefit from these agents.

Related Keywords

California , United States , San Francisco , Mark Gramling , Society For Immunotherapy Of Cancer , Lung Cancer , Ung Carcinoma , Ancer Lung , Biologic Therapy , Immunotherapy , Non Small Cell Lung Cancer , Nsclc , Brain Metastasis , Metastatic Brain Tumor , Tumor , Malignant Head And Neck Neoplasm , Metastasis , Malignant Secondary Lung Neoplasm , Etastasis Lung , Small Cell Lung Cancer , Cancer , Alignant Neoplasia , Arcinoma , Meta Analysis , Bioinformatics , Brain , Skras , K Ras , V Ki Ras2 Kirsten Rat Sarcoma Viral On ,